Despite demand, headwinds slow telehealth uptake
Telehealth services remain popular but billing and regulatory challenges are slowing its growth.
Investing. Plain and simple.
Telehealth services remain popular but billing and regulatory challenges are slowing its growth.
With its shares down 93% since its IPO, the telehealth company may try a tactic which doesn’t usually work.
IPOs carry higher risk, but this healthcare company has Telus and the UK National Health Service as clients.
With the pandemic acting as a catalyst, a spinoff of Telus Health may come sooner rather than later.
Telus, Loblaws and Well Health Technologies offer a way to capture emerging trends.